Concepedia

Ömer Acar

ÖA

Statistics

Publications

4

Citations

80

H-Index

4

Active since

2022

Affiliations

Manisa Celal Bayar University(Current)

Marmara University

Ankara Onkoloji Eğitim ve Araştırma Hastanesi

Ankara University

Adnan Menderes University

Ömer Acar is an author at Manisa Celal Bayar University specializing in molecular oncology, cancer therapeutics, and cancer research.

Top concepts

MedicineOncologyPathologyPharmacologyBreast CancerCancer TherapyCancer ResearchClinical OutcomesMolecular Oncology

Publications per year

2022–2023

4

Publications

4

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Cengiz Karaçin, Berna Öksüzoğlu, Ayşe Demirci et al. · BMC Cancer · 2023 · 23 citations · Full text

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Seda Kahraman, Enes Erul, Mustafa Seyyar et al. · Future Oncology · 2023 · 21 citations · Full text

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study

Hasan Çağrı Yıldırım, Emel Mutlu, Elvin Chalabıyev et al. · The Breast · 2022 · 19 citations · Full text

Cyclin-dependent Kinase 4–6, Breast Oncology, Oncology +9

Level of COVID-19 fear in cancer patients

Atike Pınar Erdoğan, Ferhat Ekinci, Ömer Acar et al. · Middle East Current Psychiatry · 2022 · 17 citations · Full text

Rows per page

1–4 of 4